Miri et al. demonstrated elevated FGF-23 levels in patients with end-stage renal disease (ESRD) and pulmonary hypertension, suggesting a role for FGF-23 in vascular pathology [49]. This evidence concerns the gene FGF23 and pulmonary arterial hypertension.